Search
Avadel Pharmaceuticals PLC
AVDLAdd to Watchlist
21.326USD
0.0000.00%
Close 06/24, 16:00（ET）Quotes delayed by 15 min
2.12BMarket Cap
LossP/E TTM
Revenue Breakdown
Currency: USDUpdated: Mar 3, 2025
Currency: USDUpdated: Mar 3, 2025
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Vazculep
10.43M
46.70%
Akovaz
9.54M
42.74%
Bloxiverz
2.20M
9.85%
Other
159.00K
0.71%
By RegionUSD
Name
Revenue
Proportion
United States
22.33M
100.00%
Ireland
0.00
0.00%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Vazculep
10.43M
46.70%
Akovaz
9.54M
42.74%
Bloxiverz
2.20M
9.85%
Other
159.00K
0.71%
